Material Type

• Blood (whole) (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (1)
• Plasma (single spun) (3)
• Serum (2)
• Stool (1)
• Swab medium (2)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Non-affected (2)
• Not applicable (4)

Storage Temperature

• RT (1)
• -35°C to -18°C (4)
• -85°C to -60°C (2)

Associated Data

• Biomarker datasets (3)
• Clinical records (5)
• Followup records (2)
• Freezer temperature logs (6)
• Imaging data (1)
• Microbiological results (1)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (1)
• Pre-analytical data (2)
• Primary care records (1)
• Quality indicators (3)
• Survey data (3)
• Treatment records (3)

Timeframe

• Immediate (7)
• 0 - 3 months (3)
• 3 - 6 months (1)
• > 6 months (3)

Participant Count

• 11 - 100 (4)
• 101 - 500 (3)
• 501 - 1000 (1)
• 10001 - 50000 (1)

Sex

• Unknown (1)
• Both sexes (6)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (5)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (2)
• Data analytics (1)
• Infectious strain isolation (2)
• Molecular Extractions (2)
• Nucleic acid extraction (2)

Collection Type

• Cross-sectional (2)
• Disease specific (5)
• Population-based (1)

Consent Restriction

• No Commercial restriction (2)
• No Disease area restriction (7)
• No Export restriction (7)
• No Genetic analysis restriction (3)
• No Human genetic analysis restriction (2)
• No restrictions (0)
• No Project specific restriction (7)
• No Scope of use restriction (7)

Collection Status

• Completed (4)
• In progress (3)

Access Condition

• Open to applicants (1)
• Open only through collaboration (4)
• Access restricted at present (1)
• Closed to access (1)

Country

• Belgium (1)
• Brazil (1)
• Ghana (1)
• Kenya (1)
• Peru (1)
• Uganda (1)
• United Kingdom of Great Britain and Northern Ireland (1)

County